NEW YORK (GenomeWeb News) - Johnson & Johnson Pharmaceutical Research & Development will use BioWisdom’s toxicity safety software in drug development programs, BioWisdom said today.
 
Under the three-year agreement, J&J has joined BioWisdom’s Safety Intelligence Program, which uses the company’s Sofia platform to create a “specialist medical search system” for drug safety risk assessment, BioWisdom said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.